Can-Fite BioPharma CANF
NYSE CANF
$1.77 -0.06 (-3.28%)
As of: Oct 23, 2026 · 12:10 PM EDT

Can-Fite BioPharma (CANF) Cash from Investing Activities (2012 - 2013)

Updated

Can-Fite BioPharma (CANF) posted Cash from Investing Activities of -$2,000 for FY2025, compared with $1.5 million in FY2024.

Analysis

Can-Fite BioPharma (CANF) Cash from Investing Activities (2012 - 2013) Analysis & Trends

Since FY2015, Can-Fite BioPharma has reported Cash from Investing Activities for 11 years.

  • The FY2025 figure stands as the lowest annual Cash from Investing Activities since FY2021.
  • Business Quant data shows CANF's Cash from Investing Activities at $1.5 million in FY2024 (+200.2%), $498,000 in FY2023 (-94.8%), $9.5 million in FY2022 and -$14.51 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,127.89 Bn 1,096.47 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 635.11 Bn 554.97 Bn 17.30 Bn -2.71 Bn
3 AbbVie 504.69 Bn 477.80 Bn 12.70 Bn -1.20 Bn
4 Merck 358.24 Bn 312.62 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 290.13 Bn 254.12 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.87 Bn 193.27 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn 2.11 Bn
10 Can-Fite BioPharma 1.46 Mn -18.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 -903,411.76
Jun 30, 2012 17,055.03
API Access

Can-Fite BioPharma Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=CANF&period=max&api_key=YOUR_API_KEY